T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Rollins
ROL
$28.2B
| $31.3M | ﹤0.01% |
618,017
+1,669
| +0.3% | +$84.4K |
|
877
Skyward Specialty Insurance
SKWD
$1.93B
| $31.2M | ﹤0.01% |
764,805
+687,305
| +887% | +$28M |
|
878
Liberty Broadband Class C
LBRDK
$8.72B
| $31.1M | ﹤0.01% |
401,892
+339,973
| +549% | +$26.3M |
|
|
MBX
879
MBX Biosciences, Inc. Common Stock
MBX
$334M
| $31M | ﹤0.01% |
+1,192,938
| New | +$31M |
|
880
Littelfuse
LFUS
$6.72B
| $30.9M | ﹤0.01% |
116,592
+13,946
| +14% | +$3.7M |
|
881
AnaptysBio
ANAB
$649M
| $30.9M | ﹤0.01% |
923,117
+622,893
| +207% | +$20.9M |
|
882
Sapiens International
SPNS
$2.4B
| $30.7M | ﹤0.01% |
823,008
-41,734
| -5% | -$1.56M |
|
883
Asbury Automotive
ABG
$4.97B
| $30.5M | ﹤0.01% |
127,957
+18,650
| +17% | +$4.45M |
|
884
Reddit
RDDT
$48.8B
| $30.3M | ﹤0.01% |
460,151
+148,003
| +47% | +$9.76M |
|
885
ServisFirst Bancshares
SFBS
$4.63B
| $30.3M | ﹤0.01% |
376,878
+57,118
| +18% | +$4.6M |
|
886
Crocs
CROX
$4.42B
| $30.2M | ﹤0.01% |
208,796
+2,716
| +1% | +$393K |
|
887
Cincinnati Financial
CINF
$24.5B
| $30.1M | ﹤0.01% |
221,036
+2,391
| +1% | +$325K |
|
888
Shift4
FOUR
$5.97B
| $30.1M | ﹤0.01% |
339,418
+48,014
| +16% | +$4.25M |
|
889
Addus HomeCare
ADUS
$2.07B
| $30M | ﹤0.01% |
225,549
-5,774
| -2% | -$768K |
|
890
Waters Corp
WAT
$18B
| $30M | ﹤0.01% |
83,225
+1,373
| +2% | +$494K |
|
891
Kirby Corp
KEX
$4.91B
| $29.9M | ﹤0.01% |
244,396
+212,437
| +665% | +$26M |
|
892
Campbell Soup
CPB
$10.1B
| $29.9M | ﹤0.01% |
610,729
+341,450
| +127% | +$16.7M |
|
893
Immunome
IMNM
$843M
| $29.8M | ﹤0.01% |
2,036,307
+15,188
| +0.8% | +$222K |
|
894
Sarepta Therapeutics
SRPT
$1.87B
| $29.5M | ﹤0.01% |
236,533
-103,497
| -30% | -$12.9M |
|
895
Northern Trust
NTRS
$24.7B
| $29.4M | ﹤0.01% |
326,625
-5,840
| -2% | -$526K |
|
896
Palomar
PLMR
$3.18B
| $29.3M | ﹤0.01% |
310,003
-8,730
| -3% | -$826K |
|
897
Constellium
CSTM
$2.09B
| $29.3M | ﹤0.01% |
1,799,690
+43,467
| +2% | +$707K |
|
898
DoubleVerify
DV
$2.28B
| $29.2M | ﹤0.01% |
1,735,344
+413,804
| +31% | +$6.97M |
|
899
Aptiv
APTV
$18.2B
| $29.2M | ﹤0.01% |
405,750
-384,872
| -49% | -$27.7M |
|
900
Iovance Biotherapeutics
IOVA
$876M
| $29.1M | ﹤0.01% |
3,102,912
-379,490
| -11% | -$3.56M |
|